IL10 and cancer: Suppression of IL-10 improves checkpoint blockade and reduces T cell exhaustion in mouse models of CLL [82], but counterintuitively, pegylated IL-10 can also have potent immune stimulatory effects on CD8 T cells and is being explored as an anti-cancer therapy [83].